Estrogen receptor-β in the paraventricular nucleus and rostroventrolateral medulla plays an essential protective role in aldosterone/salt-induced hypertension in female rats

Hypertension

Volumn 61, Issue 6, 2013, Pages 1255-1262

  Xue, Baojian ^a   Zhang, Zhongming ^a   Beltz, Terry G ^a   Johnson, Ralph F ^a   Guo, Fang ^a   Hay, Meredith ^d   Johnson, Alan Kim ^a,b,c  

^a E11 SSH   (United States)

^b Department of Pharmacology ^*  (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

aldosterone; blood pressure; central nervous system; estrogen receptors

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; DIARYLPROPIONITRILE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GANGLION BLOCK; HYPERTENSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SYMPATHETIC TONE;

ALDOSTERONE; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM; ESTROGEN RECEPTORS;

ALDOSTERONE; ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION; HYPERTENSION; MEDULLA OBLONGATA; NEURONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM CHLORIDE;

EID: 84878902673     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00903     Document Type: Article

References (32)

1. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol. 2000; 11: 319-329. (Pubitemid 30064855)
2. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999; 340: 1801-1811. (Pubitemid 29266405)
3. Xue B, Johnson AK, Hay M. Sex differences in angiotensin II-induced hypertension. Braz J Med Biol Res. 2007; 40: 727-734. (Pubitemid 46722220)
4. Spary EJ, Maqbool A, Batten TF. Oestrogen receptors in the central nervous system and evidence for their role in the control of cardiovascular function. J Chem Neuroanat. 2009; 38: 185-196.
5. Saleh MC, Connell BJ, Saleh TM. Autonomic and cardiovascular reflex responses to central estrogen injection in ovariectomized female rats. Brain Res. 2000; 879: 105-114.
6. Saleh MC, Connell BJ, Saleh TM. Medullary and intrathecal injections of 17beta-estradiol in male rats. Brain Res. 2000; 867: 200-209. (Pubitemid 30317397)
7. Gingerich S, Krukoff TL. Estrogen in the paraventricular nucleus attenuates L-glutamate-induced increases in mean arterial pressure through estrogen receptor beta and NO. Hypertension. 2006; 48: 1130-1136. (Pubitemid 44772718)
8. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005; 308: 1583-1587. (Pubitemid 40807497)
9. Milner TA, Drake CT, Lessard A, Waters EM, Torres-Reveron A, Graustein B, Mitterling K, Frys K, Iadecola C. Angiotensin II-induced hypertension differentially affects estrogen and progestin receptors in central autonomic regulatory areas of female rats. Exp Neurol. 2008; 212: 393-406.
10. Pamidimukkala J, Xue B, Newton LG, Lubahn DB, Hay M. Estrogen receptor-alpha mediates estrogen facilitation of baroreflex heart rate responses in conscious mice. Am J Physiol Heart Circ Physiol. 2005; 288: H1063-H1070. (Pubitemid 40270008)
11. Xue B, Pamidimukkala J, Lubahn DB, Hay M. Estrogen receptoralpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol. 2007; 292: H1770-H1776. (Pubitemid 46572400)
12. Shih CD. Activation of estrogen receptor beta-dependent nitric oxide signaling mediates the hypotensive effects of estrogen in the rostral ventrolateral medulla of anesthetized rats. J Biomed Sci. 2009; 16: 60.
13. Yoshimoto T, Hirata Y. Aldosterone as a cardiovascular risk hormone. Endocr J. 2007; 54: 359-370. (Pubitemid 47105422)
14. Gomez-Sanchez EP, Gomez-Sanchez CE. Central regulation of blood pressure by the mineralocorticoid receptor. Mol Cell Endocrinol. 2012; 350: 289-298.
15. Xue B, Badaue-Passos D Jr, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone/NaCl-induced hypertension. Am J Physiol Heart Circ Physiol. 2009; 296: H1577-H1585.
16. Emmen JM, Korach KS. Estrogen receptor knockout mice: phenotypes in the female reproductive tract. Gynecol Endocrinol. 2003; 17: 169-176. (Pubitemid 36461461)
17. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science. 2002; 295: 505-508. (Pubitemid 34101642)
18. Tremblay AM, Dufour CR, Ghahremani M, Reudelhuber TL, Giguère V. Physiological genomics identifies estrogen-related receptor alpha as a regulator of renal sodium and potassium homeostasis and the renin-angiotensin pathway. Mol Endocrinol. 2010; 24: 22-32.
19. Pelzer T, Jazbutyte V, Hu K, Segerer S, Nahrendorf M, Nordbeck P, Bonz AW, Muck J, Fritzemeier KH, Hegele-Hartung C, Ertl G, Neyses L. The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovasc Res. 2005; 67: 604-612. (Pubitemid 41033356)
20. Arias-Loza PA, Hu K, Dienesch C, Mehlich AM, König S, Jazbutyte V, Neyses L, Hegele-Hartung C, Heinrich Fritzemeier K, Pelzer T. Both estrogen receptor subtypes, alpha and beta, attenuate cardiovascular remodeling in aldosterone salt-treated rats. Hypertension. 2007; 50: 432-438. (Pubitemid 47205796)
21. Gürgen D, Hegner B, Kusch A, Catar R, Chaykovska L, Hoff U, Gross V, Slowinski T, da Costa Goncalves AC, Kintscher U, Gustafsson JÅ, Luft FC, Dragun D. Estrogen receptor-beta signals left ventricular hypertrophy sex differences in normotensive deoxycorticosterone acetate-salt mice. Hypertension. 2011; 57: 648-654.
22. Stern JE, Zhang W. Preautonomic neurons in the paraventricular nucleus of the hypothalamus contain estrogen receptor beta. Brain Res. 2003; 975: 99-109. (Pubitemid 36588556)
23. Geerling JC, Shin JW, Chimenti PC, Loewy AD. Paraventricular hypothalamic nucleus: Axonal projections to the brainstem. J Comp Neurol. 2010; 518: 1460-1499.
24. Geerling JC, Loewy AD. Aldosterone in the brain. Am J Physiol Renal Physiol. 2009; 297: F559-F576.
25. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 1993; 7: 678-686. (Pubitemid 23163603)
26. Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol. 2008; 294: H1067-H1074. (Pubitemid 351253321)
27. Xue B, Beltz TG, Yu Y, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Central interactions of aldosterone and angiotensin II in aldosterone-and angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol. 2011; 300: H555-H564.
28. Xue B, Beltz TG, Johnson RF, Guo F, Hay M, Johnson AK. PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuate aldosterone/NaCl-induced hypertension in mice. Am J Physiol Heart Circ Physiol. 2012; 302: H733-H741.
29. Xue B, Zhao Y, Johnson AK, Hay M. Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species. Am J Physiol Heart Circ Physiol. 2008; 295: H1025-H1032.
30. Shimada K, Kitazato KT, Kinouchi T, Yagi K, Tada Y, Satomi J, Kageji T, Nagahiro S. Activation of estrogen receptor-? and of angiotensin-converting enzyme 2 suppresses ischemic brain damage in oophorectomized rats. Hypertension. 2011; 57: 1161-1166.
31. Pak TR, Chung WC, Roberts JL, Handa RJ. Ligand-independent effects of estrogen receptor beta on mouse gonadotropin-releasing hormone promoter activity. Endocrinology. 2006; 147: 1924-1931.
32. Sigmund CD, Davisson RL. Targeting brain AT1 receptors by RNA interference. Hypertension. 2006; 47: 145-146. (Pubitemid 43189754)